Shopping Cart
- Remove All
Your shopping cart is currently empty
ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $3,320 | 10-14 weeks | |
| 50 mg | $4,380 | 10-14 weeks | |
| 100 mg | $6,100 | 10-14 weeks |
| Description | ETX0282 is an orally available, broad spectrum inhibitor of class A and C β-lactamases. Entasis is developing ETX0282 in combination with cefpodoxime proxetil, an orally available cephalosporin approved for treatment of a variety of bacterial infections. |
| Molecular Weight | 315.30 |
| Formula | C13H18FN3O5 |
| Cas No. | 2209871-83-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.